Search Results - "FORBES, R. D. C"

Refine Results
  1. 1

    The impact of renal transplantation on the course of hepatitis B liver disease by Parfrey, P S, Forbes, R D, Hutchinson, T A, Kenick, S, Farge, D, Dauphinee, W D, Seely, J F, Guttmann, R D

    Published in Transplantation (01-06-1985)
    “…To establish the impact of transplantation on the course of chronic hepatitis B liver disease we performed a prospective study of the clinical and pathological…”
    Get more information
    Journal Article
  2. 2

    Reduction of azathioprine in renal transplant patients with chronic hepatitis by Farge, D, Parfrey, P S, Forbes, R D, Dandavino, R, Guttmann, R D

    Published in Transplantation (01-01-1986)
    “…To determine whether prolonged reduction of azathioprine in renal transplant recipients with chronic hepatitis affected the progression of liver disease…”
    Get more information
    Journal Article
  3. 3

    Endothelin-1 immunoreactivity and mRNA in the transplanted human heart by Giaid, A, Saleh, D, Yanagisawa, M, Forbes, R D

    Published in Transplantation (15-05-1995)
    “…Endothelin-1 (ET-1) is a 21-residue peptide produced by endothelial cells and possesses a wide range of biological activities, including vasoconstriction,…”
    Get more information
    Journal Article
  4. 4

    Increased endothelin expression in a rat cardiac allograft model of chronic vascular rejection by FORBES, R. D. C, CERNACEK, P, ZHENG, S.-X, GOMERSALL, M, GUTTMANN, R. D

    Published in Transplantation (15-03-1996)
    “…Endothelins (ET) are potent vasoconstrictors that are directly mitogenic for vascular smooth muscle cells and fibroblasts. It is possible that the…”
    Get full text
    Journal Article
  5. 5

    Successful treatment of post-transplant lymphoproliferative disorder with interferon-alpha and intravenous immunoglobulin by Cantarovich, M, Barkun, J S, Forbes, R D, Kosiuk, J P, Tchervenkov, J I

    Published in Clinical transplantation (01-04-1998)
    “…We report on the use of interferon-alpha (INF-a) and high-dose non-specific intravenous immunoglobulin (IVIg) in 2 patients (a 60-yr-old female and a 65-yr-old…”
    Get more information
    Journal Article
  6. 6

    Irreversible chronic vascular rejection occurs only after development of advanced allograft vasculopathy : A comparative study of a rat cardiac allograft model using a retransplantation protocol by FORBES, R. D. C, ZHENG, S.-X, GOMERSALL, M, GUTTMANN, R. D

    Published in Transplantation (15-03-1997)
    “…Indefinitely surviving WF.1L (RT1(1)) cardiac allografts transplanted to LEW (RT1(1)) recipients provide an ideal model for controlled comparative studies of…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The pathophysiology of chronic rejection by Guttmann, R D, Forbes, R D, Zheng, S X

    “…The understanding of chronic rejection has been greatly enhanced by the use of genetically controlled experimental models using inbred rats. Models that…”
    Get more information
    Journal Article
  9. 9

    Cyclosporine and the reversibility of chronic vascular rejection by Guttmann, R D, Forbes, R D, Zheng, S, Busque, S

    Published in Transplantation proceedings (01-10-1994)
    “…A model of chronic vascular rejection of cardiac allografts has been developed in inbred rats using the WF.1L/Gut congenic strain as donor into LEW recipients…”
    Get more information
    Journal Article
  10. 10

    Dendritic cell-lymphoid cell aggregation and major histocompatibility antigen expression during rat cardiac allograft rejection by FORBES, R. D. C, PARFREY, N. A, GOMERSALL, M, DARDEN, A. G, GUTTMANN, R. D

    Published in The Journal of experimental medicine (01-10-1986)
    “…To determine the pattern of cellular expression of donor MHC class I and class II antigens during the course of rat cardiac allograft rejection, ACI cardiac…”
    Get full text
    Journal Article
  11. 11

    Endocardial infiltrates in human heart transplants: a serial biopsy analysis comparing four immunosuppression protocols by Forbes, R D, Rowan, R A, Billingham, M E

    Published in Human pathology (1990)
    “…Endocardial mononuclear cell infiltrates were studied in 2,350 consecutive biopsies from 172 patients over a period ranging from 4 to 16 months post cardiac…”
    Get more information
    Journal Article
  12. 12

    CD4+/Leu-7+ large granular lymphocytes in long-term renal allograft recipients. A subset of atypical T cells by Legendre, C M, Forbes, R D, Loertscher, R, Guttmann, R D

    Published in Transplantation (01-06-1989)
    “…In long-term renal allograft recipients on conventional immunosuppression, we have previously reported an abnormal expansion of CD3+/Leu-7+ cells. These cells…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    Immune mechanisms in organ allograft rejection. I. Delayed-type hypersensitivity and lymphocytotoxicity in heart graft rejection by Lowry, R P, Gurley, K E, Forbes, R D

    Published in Transplantation (01-10-1983)
    “…Sublethally irradiated (780 rads) rats receiving fully allogeneic heart transplants were reconstituted with sensitized lymphocytes fractionated into helper and…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Expression of early and late activation markers on peripheral blood T lymphocytes does not reliably reflect immune events in transplanted hearts by Loertscher, R, Forbes, R D, Halabi, G, Lavery, P, Quinn, T

    Published in Clinical transplantation (01-06-1994)
    “…Monoclonal antibodies directed against early (receptors for interleukin-2 and transferrin [IL-2R, TfR]) and late (PTA1, alpha 1 integrin VLA-1) activation…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20